Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences and challenges of people with multiple sclerosis and low attendance to clinical follow-up: a qualitative study.

BMC neurology·2025
Same author

The effect of 2 different premilking stimulation regimens, with and without a latency period, on teat tissue condition and milking performance in Holstein dairy cows.

Journal of dairy science·2023
Same author

Adherence to dietary guidelines and risk of dementia: a prospective cohort study of 94 184 individuals.

Epidemiology and psychiatric sciences·2022
Same author

Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls.

HIV medicine·2020
Same author

Contribution of remnant cholesterol to cardiovascular risk.

Journal of internal medicine·2020
Same author

Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Related Experiment Video

Updated: Jun 6, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Scavenger receptor AI/II truncation, lung function and COPD: a large population-based study.

M Thomsen1, B G Nordestgaard, A Tybjaerg-Hansen

  • 1Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

Journal of Internal Medicine
|November 17, 2010
PubMed
Summary

The scavenger receptor A-I/II (SRA-I/II) Arg293X variant is linked to reduced lung function and increased COPD risk in men. This genetic variant also impacts lung function in individuals with specific alpha-1-antitrypsin and superoxide dismutase genotypes.

Related Experiment Videos

Last Updated: Jun 6, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Area of Science:

  • Genetics
  • Pulmonology
  • Immunology

Background:

  • The scavenger receptor A-I/II (SRA-I/II) plays a crucial role in the lung's defense against modified lipids and inhaled particles.
  • A specific genetic variant, Arg293X, in the SRA-I/II gene leads to a truncated protein, potentially impairing its function in ligand recognition.

Purpose of the Study:

  • To investigate the association between the SRA-I/II Arg293X variant and lung function.
  • To determine if the Arg293X variant increases the risk of chronic obstructive pulmonary disease (COPD) in the general population.

Main Methods:

  • Genotyping of 48,741 individuals from the Danish general population for the Arg293X variant.
  • Assessment of lung function parameters (FVC and FEV1) and spirometry-defined COPD.

Main Results:

  • Arg293X heterozygotes showed a statistically significant reduction in forced vital capacity (FVC) and forced expiratory volume in one second (FEV1) among men.
  • The Arg293X variant interacted with gender and alpha(1)-antitrypsin MZ heterozygosity, influencing lung function.
  • A significant association was found between Arg293X heterozygosity and increased risk of COPD in men (OR 1.7).

Conclusions:

  • The SRA-I/II Arg293X variant is associated with reduced lung function and elevated COPD risk, particularly in men.
  • Interactions between Arg293X, gender, and other genetic factors (alpha(1)-antitrypsin MZ, superoxide dismutase-3 E1I1) influence lung function outcomes.